✦ LIBER ✦

The pathobiologic features of carcinomas of type II pneumocytes. An immunocytologic study

✍ Scribed by Gurmukh Singh; Bernd W. Scheithauer; Sikandar L. Katyal

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 734 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860301)57:5<994::aid-cncr2820570520>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A quantitative study of the development

A quantitative study of the development of type II pneumocytes in fetal lung

✍ Dr. J. F. Leary; J. N. Finkelstein; R. H. Notter; D. L. Shapiro 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

Flow cytometric study of the type II pne

Flow cytometric study of the type II pneumocyte cell cycle in vivo and in vitro

✍ Bruce D. Uhal 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB

Ultrastructure of canine type II pneumoc

Ultrastructure of canine type II pneumocytes during hypothermic ischemia of the lung: A study by means of conventional and energy filtering transmission electron microscopy and stereology

✍ Ochs, Matthias ;Fehrenbach, Heinz ;Richter, Joachim 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

Cisplatin and gemcitabine with either vi

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian Multicenter, randomized, phase II study

✍ Sergio Palmeri; Vito Lorusso; Laura Palmeri; Marina Vaglica; Camillo Porta; Rola 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

## Abstract ## BACKGROUND. To date, the standard treatment for patients who have carcinoma of unknown primary site has not been established. ## METHODS. In this randomized Phase II study, 66 previously untreated patients (33 patients per arm) with carcinomas of unknown primary site received cisp

Roles of the transforming growth factor

Roles of the transforming growth factor β1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: Results of an immunohistochemical study

✍ Takanami, Iwao; Tanaka, Fumihiko; Hashizume, Toshinori; Kodaira, Susumu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

## Background: In the united states, pulmonary adenocarcinomas have recently replaced squamous cell carcinomas as the most frequent type of lung cancer encountered. the incidence of pulmonary adenocarcinoma continued to increase worldwide. ## Method: To determine the roles of the transforming gro

A phase II study of 5-fluorouracil, leuc

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext